These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 7381469)

  • 41. Comparison of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridinium (MPP+) effects on mouse heart norepinephrine.
    Fuller RW; Hemrick-Luecke SK; Robertson DW
    Biochem Pharmacol; 1988 Sep; 37(17):3343-7. PubMed ID: 3135812
    [TBL] [Abstract][Full Text] [Related]  

  • 42. dl-N-methyl-3-(o-methoxyphenoxy)-3-phenylpropylamine hydrochloride, Lilly 94939, a potent inhibitor for uptake of norepinephrine into rat brain synaptosomes and heart.
    Wong DT; Horng JS; Bymaster FP
    Life Sci; 1975 Sep; 17(5):755-60. PubMed ID: 1207394
    [No Abstract]   [Full Text] [Related]  

  • 43. Dopamine and norepinephrine uptake by rat brain synaptosomes: relative inhibitory potencies of 1- and d-amphetamine and amantadine.
    Thornburg JE; Moore KE
    Res Commun Chem Pathol Pharmacol; 1973 Jan; 5(1):81-9. PubMed ID: 4686111
    [No Abstract]   [Full Text] [Related]  

  • 44. Monoamine uptake into synaptosomes from various regions of rat brain following lithium administration and withdrawal.
    Ahluwalia P; Singhal RL
    Neuropharmacology; 1981 May; 20(5):483-7. PubMed ID: 6787450
    [No Abstract]   [Full Text] [Related]  

  • 45. Regulation of catecholamine synthesis in rat brain synaptosomes.
    Patrick RL; Barchas JD
    J Neurochem; 1974 Jul; 23(1):7-15. PubMed ID: 4153038
    [No Abstract]   [Full Text] [Related]  

  • 46. Effect of sympathomimetic amines on the synaptosomal transport of noradrenaline, dopamine and 5-hydroxytryptamine.
    Raiteri M; Del Carmine R; Bertollini A; Levi G
    Eur J Pharmacol; 1977 Jan; 41(2):133-43. PubMed ID: 832672
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Activation by S-adenosylhomocysteine of norepinephrine and serotonin in vitro uptake in synaptosomal preparations from rat brain.
    Fonlupt P; Roche M; Cronenberger L; Pacheco H
    Experientia; 1979 Aug; 35(8):1089-90. PubMed ID: 477888
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ageing and dopamine uptake by subcellular fractions of the C57BL/6J male mouse brain.
    Jonec V; Finch CE
    Brain Res; 1975 Jun; 91(2):197-215. PubMed ID: 1164671
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Release of somatostatin from rat brain synaptosomes.
    Bennett GW; Edwardson JA; Marcano de Cotte M; Berelowitz M; Pimstone BL; Kronheim S
    J Neurochem; 1979 Mar; 32(3):1127-30. PubMed ID: 430048
    [No Abstract]   [Full Text] [Related]  

  • 50. Dopamine uptake in striatal and hypothalamic synaptosomes: conformational selectivity of the inhibition.
    Tuomisto L; Tuomisto J; Smissman EE
    Eur J Pharmacol; 1974 Mar; 25(3):351-61. PubMed ID: 4827861
    [No Abstract]   [Full Text] [Related]  

  • 51. Inhibition of synaptosomal uptake of norepinephrine and dopamine by conformationally restricted sympathomimetic amines.
    Komiskey HL; Hsu FL; Bossart FJ; Fowble JW; Miller DD; Patil PN
    Eur J Pharmacol; 1978 Nov; 52(1):37-45. PubMed ID: 720387
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Regional differences in the high affinity uptake or 3H-dopamine and 3H-norepinephrine in synaptosome rich homogenates of cat brain.
    Garey RE
    Life Sci; 1976 Feb; 18(4):411-8. PubMed ID: 1256245
    [No Abstract]   [Full Text] [Related]  

  • 53. The effect of desipramine on the uptake of mescaline by cortical synaptosomes.
    Bevan P; Bradshaw CM; Szabadi E
    Biochem Pharmacol; 1977 Feb; 26(3):207-10. PubMed ID: 843389
    [No Abstract]   [Full Text] [Related]  

  • 54. The effects of chronic manganese chloride treatment expressed as age-dependent, transient changes in rat brain synaptosomal uptake of amines.
    Lai JC; Leung TK; Guest JF; Davison AN; Lim L
    J Neurochem; 1982 Mar; 38(3):844-7. PubMed ID: 7057197
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of phenethylamine derivatives on the release of biogenic amines from synaptosomes.
    Raiteri M; Bertollini A; del Carmine R; Levi G
    Biochem Soc Trans; 1976; 4(1):121-4. PubMed ID: 1001613
    [No Abstract]   [Full Text] [Related]  

  • 56. Effects of amphetamines on the metabolism of catecholamines in the rat brain.
    Baldessarini RJ; Harris JE
    J Psychiatr Res; 1974; 11():41-3. PubMed ID: 4477777
    [No Abstract]   [Full Text] [Related]  

  • 57. Neurotoxicity of hydroxylated tryptamines: structure-activity relationships. 2. In vitro studies on monoamine uptake inhibition and uptake impairment.
    Björklund A; Horn AS; Baumgarten HG; Nobin A; Schlossberger HG
    Acta Physiol Scand Suppl; 1975; 429():29-60. PubMed ID: 1064286
    [No Abstract]   [Full Text] [Related]  

  • 58. The effect of nefopam and its enantiomers on the uptake of 5-hydroxytryptamine, noradrenaline and dopamine in crude rat brain synaptosomal preparations.
    Rosland JH; Hole K
    J Pharm Pharmacol; 1990 Jun; 42(6):437-8. PubMed ID: 1979627
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effect of narcotic analgesic drugs on the uptake and release of neurotransmitters in isolated synaptosomes.
    Clouet DH; Williams N
    J Pharmacol Exp Ther; 1974 Feb; 188(2):419-28. PubMed ID: 4811303
    [No Abstract]   [Full Text] [Related]  

  • 60. Effects of cannabinoids on catecholamine uptake and release in hypothalamic and striatal synaptosomes.
    Poddar MK; Dewey WL
    J Pharmacol Exp Ther; 1980 Jul; 214(1):63-7. PubMed ID: 7391971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.